Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | HPGDS | O60760 | 1/20 | 0.40 |
| ▸ | AMY1A | P0DUB6 | 3/20 | 0.39 |
| ▸ | ACLY | P53396 | 2/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.36 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.36 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.36 |
| ▸ | STK39 | Q9UEW8 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22195646 | 0.83 | IDO1 (0.39) | HSP90AA1MAPTMEN1KMT2ACA1 | |
| SCHEMBL20739878 | 0.81 | AMY1A (0.42) | ALDH1A1CYP3A4TSHRRECQLHSD17B10 | |
| SCHEMBL19802353 | 0.81 | EPHX2 (0.41) | ALDH1A1TSHRHSD17B10HSP90AA1MAPT | |
| SCHEMBL20982342 | 0.79 | CXCR2 (0.40) | ALDH1A1CYP3A4TSHRHSD17B10HSP90AA1 | |
| SCHEMBL23299465 | 0.73 | ALDH1A1 (0.43) | ALDH1A1CYP3A4TSHRRECQLHSD17B10 | |
| SCHEMBL19802270 | 0.73 | PTGES (0.39) | MEN1KMT2AMAPK1LMNAHTT | |
| SCHEMBL22592903 | 0.73 | GABRA1 (0.48) | CYP3A4TSHRAMY1AMEN1KMT2A | |
| SCHEMBL24295514 | 0.72 | ALDH1A1 (0.42) | ALDH1A1CYP3A4TSHRRECQLHSD17B10 | |
| SCHEMBL22884859 | 0.71 | TSHR (0.41) | ALDH1A1TSHRHSP90AA1MAPTKDM4E | |
| SCHEMBL22129740 | 0.71 | CA1 (0.37) | ALDH1A1MAPK1TTRHTTCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11802123-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-10-31 | — | — | US | disclosed |
| US-11802123-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2023-10-31 | — | — | US | disclosed |
| US-20220064153-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2022-03-03 | — | — | US | disclosed |
| EP-3415512-B1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME | LG CHEMICAL LTD (KR) | 2021-04-28 | — | — | EP | disclosed |
| US-10818848-B2 | Organic light emitting device | LG CHEM, LTD. (KR) | 2020-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11802123-B2 | Heterocyclic compound and organic light emitting device comprising the same | CRY1, CRY2, PPOX | ALDH1A1 76/4885CYP3A4 15/4885TSHR 3876/4885 |
| US-20220064153-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, ORC3 | ALDH1A1 94/4885CYP3A4 21/4885TSHR 4111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.